T Amagata TA Johnson RH Cichewicz K Tenney SL Mooberry J Media M Edelstein FA Valeriote P Crews 2008 J Med Chem 51 7234 7242 10.1021/jm8008585 1:CAS:528:DC%2BD1cXht1Ors7rK
High rates of actin filament turnover in budding yeast and roles for actin in establishment and maintenance of cell polarity revealed using the actin inhibitor latrunculin-A
DOI 10.1083/jcb.137.2.399
KR Ayscough J Stryker N Pokala M Sanders P Crews DG Drubin 1997 J Cell Biol 137 399 416 10.1083/jcb.137.2.399 1:CAS:528:DyaK2sXislKltL4%3D (Pubitemid 27181293)
Characterization of the activities of actin-affecting drugs on tumor cell migration
DOI 10.1016/j.taap.2005.06.006, PII S0041008X05003625
C Hayot O Debeir P Van Ham M Van Damme R Kiss C Decaestecker 2006 Toxicol Appl Pharmacol 211 30 40 10.1016/j.taap.2005.06.006 1:CAS:528: DC%2BD28XhtFWjt7c%3D (Pubitemid 43152095)
SA Ahmed S Odde PR Daga JJ Bowling MK Mesbah DT Youssef SI Khalifa RJ Doerksen MT Hamann 2007 Org Lett 9 4773 4776 10.1021/ol7020675 1:CAS:528:DC%2BD2sXhtFGisrvE
Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells
DOI 10.1021/np070587w
KA ElSayed MA Khanfar HM Shallal A Muralidharan B Awate DTA Youssef Y Liu YD Zhoo DG Nagle G Shah 2008 J Nat Prod 71 396 402 10.1021/np070587w 1:CAS:528:DC%2BD1cXitl2lsbs%3D (Pubitemid 351549362)